These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19621834)

  • 41. Obsessive compulsive disorder and depression--first results of a prospective study on 74 patients.
    Demal U; Zitterl W; Lenz G; Zapotoczky HG; Zitterl-Eglseer K
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):801-13. PubMed ID: 8870065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders].
    Voderholzer U; Favreau M; Rubart A; Staniloiu A; Wahl-Kordon A; Zurowski B; Kathmann N
    Nervenarzt; 2022 Jul; 93(7):678-687. PubMed ID: 35763051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obsessive-compulsive disorder: a concealed diagnosis.
    Nymberg JH; Van Noppen B
    Am Fam Physician; 1994 Apr; 49(5):1129-37, 1142-4. PubMed ID: 8154402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suicide in patients treated for obsessive-compulsive disorder: a prospective follow-up study.
    Alonso P; Segalàs C; Real E; Pertusa A; Labad J; Jiménez-Murcia S; Jaurrieta N; Bueno B; Vallejo J; Menchón JM
    J Affect Disord; 2010 Aug; 124(3):300-8. PubMed ID: 20060171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder.
    Simpson HB; Liebowitz MR; Foa EB; Kozak MJ; Schmidt AB; Rowan V; Petkova E; Kjernisted K; Huppert JD; Franklin ME; Davies SO; Campeas R
    Depress Anxiety; 2004; 19(4):225-33. PubMed ID: 15274171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Summary of the practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. American Academy of Child and Adolescent Psychiatry.
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1110-6. PubMed ID: 9785724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
    Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
    J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package.
    March JS; Mulle K; Herbel B
    J Am Acad Child Adolesc Psychiatry; 1994; 33(3):333-41. PubMed ID: 8169177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obsessive-compulsive disorder: unearthing a hidden problem.
    El-Sayegh S; Bea S; Agelopoulos A
    Cleve Clin J Med; 2003 Oct; 70(10):824-5, 829-30, 832-3, passim. PubMed ID: 14621230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
    Denys D
    Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obsessive-compulsive disorder.
    Aljeshi A
    Neurosciences (Riyadh); 2011 Oct; 16(4):313-9. PubMed ID: 21983372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obsessive-compulsive disorder: diagnosis and treatment.
    Goodman WK
    J Clin Psychiatry; 1999; 60 Suppl 18():27-32. PubMed ID: 10487253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.
    Sousa MB; Isolan LR; Oliveira RR; Manfro GG; Cordioli AV
    J Clin Psychiatry; 2006 Jul; 67(7):1133-9. PubMed ID: 16889458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Again and again--the obsessive circle can be broken].
    Rück C; Andersson EM; Andréewitch S; Bejerot S; Ivarsson T; Bates S; Lindefors N
    Lakartidningen; 2011 Apr 6-12; 108(14):798-801. PubMed ID: 21638920
    [No Abstract]   [Full Text] [Related]  

  • 59. Commonly asked questions in the treatment of obsessive-compulsive disorder.
    Arumugham SS; Reddy YC
    Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
    Kordon A; Broocks A; Hohagen F
    MMW Fortschr Med; 2003 May; 145 Suppl 2():4-7. PubMed ID: 14579475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.